Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gibb

Showing results (361-370 of 368) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 368 results.
HIV Medicine|September 15, 2016
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in EuropeA Judd, R Lodwick, A Noguera-Julian, et al.
The New England Journal of Medicine|March 9, 2022
Shorter Treatment for Nonsevere Tuberculosis in African and Indian ChildrenAnna Turkova, Genevieve H Wills, Eric Wobudeya, et al.
Eclinicalmedicine|June 12, 2023
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trialAlexandra Compagnucci, Man K Chan, Yacine Saïdi, et al.
The New England Journal of Medicine|May 14, 2025
Second-Line Antiretroviral Therapy for Children Living with HIV in AfricaVictor Musiime, Mutsa Bwakura-Dangarembizi, Alexander J Szubert, et al.
The Lancet. Infectious Diseases|September 29, 2024
Advancing the chemotherapy of tuberculous meningitis: a consensus viewSean Wasserman, Joseph Donovan, Evelyne Kestelyn, et al.
The New England Journal of Medicine|December 29, 2021
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in ChildrenAnna Turkova, Ellen White, Hilda A Mujuru, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2021
Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling AnalysisCharles Whittaker, Oliver J Watson, Carlos Alvarez-Moreno, et al.
Lancet (London, England)|December 17, 2009
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial, P Mugyenyi, A S Walker, et al.
Pageof 37

Showing results (361-370 of 368) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 368 results.
HIV Medicine|September 15, 2016
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in EuropeA Judd, R Lodwick, A Noguera-Julian, et al.
The New England Journal of Medicine|March 9, 2022
Shorter Treatment for Nonsevere Tuberculosis in African and Indian ChildrenAnna Turkova, Genevieve H Wills, Eric Wobudeya, et al.
Eclinicalmedicine|June 12, 2023
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trialAlexandra Compagnucci, Man K Chan, Yacine Saïdi, et al.
The New England Journal of Medicine|May 14, 2025
Second-Line Antiretroviral Therapy for Children Living with HIV in AfricaVictor Musiime, Mutsa Bwakura-Dangarembizi, Alexander J Szubert, et al.
The Lancet. Infectious Diseases|September 29, 2024
Advancing the chemotherapy of tuberculous meningitis: a consensus viewSean Wasserman, Joseph Donovan, Evelyne Kestelyn, et al.
The New England Journal of Medicine|December 29, 2021
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in ChildrenAnna Turkova, Ellen White, Hilda A Mujuru, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2021
Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling AnalysisCharles Whittaker, Oliver J Watson, Carlos Alvarez-Moreno, et al.
Lancet (London, England)|December 17, 2009
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial, P Mugyenyi, A S Walker, et al.
Pageof 37